-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$191.000.24% Upside
Krystal Biotech, Inc. Frequently Asked Questions
-
What analysts cover Krystal Biotech, Inc.?
Krystal Biotech, Inc. has been rated by research analysts at Stifel Nicolaus, Bank of America Securities, Evercore ISI, Chardan Capital in the past 90 days.